Umetsu Dale T, DeKruyff Rosemarie H
Division of Immunology, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.
Immunol Rev. 2006 Aug;212:238-55. doi: 10.1111/j.0105-2896.2006.00413.x.
Allergic diseases and asthma are caused by exaggerated T-helper 2 (Th2)-biased immune responses in genetically susceptible individuals. Tolerance to allergens is a mechanism that normally prevents such responses, but the specific immunological events that mediate tolerance in this setting are poorly understood. A number of recent studies indicate that regulatory T cells (Tregs) play an important role in controlling such Th2-biased responses. Tregs involved in regulating allergy and asthma consist of a family of related types of T cells, including natural CD25+ Tregs as well as inducible forms of antigen-specific adaptive Tregs. Impaired expansion of natural and/or adaptive Tregs is hypothesized to lead to the development of allergy and asthma, and treatment to induce allergen-specific Tregs could provide curative therapies for these problems.
过敏性疾病和哮喘是由遗传易感性个体中过度的辅助性T细胞2(Th2)偏向性免疫反应引起的。对过敏原的耐受性是一种通常可预防此类反应的机制,但在此情况下介导耐受性的具体免疫事件却知之甚少。最近的一些研究表明,调节性T细胞(Tregs)在控制此类Th2偏向性反应中发挥着重要作用。参与调节过敏和哮喘的Tregs由一系列相关类型的T细胞组成,包括天然CD25 + Tregs以及抗原特异性适应性Tregs的诱导形式。据推测,天然和/或适应性Tregs的扩增受损会导致过敏和哮喘的发生,而诱导过敏原特异性Tregs的治疗可为这些问题提供治愈性疗法。